Trends are exclusive digital series focusing on the most crucial topics and issues facing today's laboratory professionals.
6-Part Series
Laboratory-Developed Tests
On April 29, the FDA announced a final rule amending the FDA’s regulations explicitly stating that IVDs, including lab-developed tests or LDTs, are devices under the Federal Food, Drug, and Cosmetic Act. Here's everything you need to know to navigate the new LDTs regulations.
The emergence of new coronavirus variants is placing extra pressure on health systems, epidemiological efforts, and diagnostic teams, including concerns that mutations could interfere with vaccine efficacy and COVID-19 testing. This series examines key considerations for laboratories conducting COVID-19 testing.
How can your lab can do its part toward becoming more sustainable? This series highlights ways to implement sustainability and "green labs" initiatives in your clinical lab in light of limited resources and budgets.
This series delves into essential professional networking tips and strategies. From the fundamentals of online networking, particularly on platforms like LinkedIn, to the value of in-person networking, learn how to make genuine connections and elevate your professional career.
Staff shortages plague clinical laboratories across the country. This series will provide helpful tips for recruiting and retaining star employees to your lab to build an exceptional team.
Automation is becoming ubiquitous across clinical laboratories. This series explores critical questions to consider when automating your lab including how to avoid common automation pitfalls, how automation can improve quality, and how it will impact staff.
Cancer is one of the most common diseases in the world. Yet, unlike many other life-threatening diseases, laboratory diagnostics of cancer remains limited. This series will explore cancer diagnostics from a variety of perspectives.
Innovative molecular diagnostics technologies are critical to overcoming current health care challenges and improving the way patients are diagnosed and treated. This series discusses the latest advances in molecular methods.
Artificial intelligence is changing the face of health care. This series will help clinical laboratory leaders and staff navigate this new and exciting (and, for some, frightening) terrain.
As a clinical tool, mass spectrometry boasts high analytical specificity and sensitivity, multiplexing capability, and low sample cost. This series will explore the latest advances in clinical mass spectrometry.
Advancing artificial intelligence pathology and multi-omics data integration is quickly expanding the role of clinical informatics in health care. Laboratory processes, the quality of the data, and its speed of transmission are critical factors in serving patients and populations. This series will offer clinical leaders insights and practical solutions to bringing the lab and informatics tools together.
